Who has invested in BostonGene?

NEC Corporation, Japan Industrial Partners, Impact Investment Capital are named among the investors backing BostonGene.

BostonGene Funding: $200M Raised, Series B (2022)

BostonGene funding overview

BostonGene is based in Waltham. BostonGene has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2022. The round record for BostonGene runs through 2022; nothing later has been disclosed. Investors on record include NEC Corporation, Japan Industrial Partners, Impact Investment Capital. 3 distinct backers are named across the disclosed rounds.

BostonGene at a glance

Total raised: $200M
Latest round: Series B
Latest round date: April 2022
Headquarters: Waltham
Notable investors: NEC Corporation, Japan Industrial Partners, Impact Investment Capital

Frequently asked about BostonGene funding

How much has BostonGene raised?: BostonGene has raised $200M in total disclosed funding across the rounds on record.
Who has invested in BostonGene?: NEC Corporation, Japan Industrial Partners, Impact Investment Capital are named among the investors backing BostonGene.
What was the latest BostonGene funding round?: The most recent disclosed round is a Series B, announced in April 2022.
Where is BostonGene based?: BostonGene is based in Waltham.
When did BostonGene last raise?: The last disclosed BostonGene round closed in April 2022 at Series B.

Totals shown for BostonGene aggregate every disclosed round on file. To see how that compares, browse the companies in Waltham and the investors behind them below.

BostonGene Funding: $200M Raised, Series B (2022)

BostonGene funding overview

BostonGene at a glance

Frequently asked about BostonGene funding

Companies related to BostonGene (20)

Browse related funding lists (3)